Contents:

SUMMARY OPERATING RESULTS...........................................................................................................................................................................................................iii OVERVIEW Recent Key Events FINANCIAL REVIEW First Half 2009 Financial Results Bard - First and Second Quarter 2009 Financial Results Bard - First and Second Quarter 2009 Sales by Product Area Bard - First and Second Quarter 2009 Sales by Geographic Area Vascular Products Urology Products Oncology Products Surgical Specialty Products Other Products 2008 Financial Results Bard - Annual Financial Results, 2004-2008 Bard - Annual Revenues and Operating Income, 2004-2008 Bard - Annual Sales by Geographic Area, 2005-2008 Bard - Annual Sales by Geographic Area, 2005-2008 Bard - Annual Sales by Product Area, 2005-2008 Bard - Annual Sales by Product Area, 2005-2008 Vascular Products Urology Products Oncology Products Surgical Specialty Products Other Products Five-Year Financial Data Bard - Five-Year Financial Summary, 2004-2008 Outlook Employees STRATEGIC FOCUS PRODUCTS Bard – Product Contributions to Net Sales, 2006-2008 Bard - 2008 Sales by Product Group Vascular Products Key Vascular Products Bard - Annual Vascular Sales, 2005-2008 Bard – Recent Vascular Product FDA Approvals Urology Products Key Urology Products Bard - Annual Urology Sales, 2005-2008 Bard – Recent Urology Product FDA Approvals Oncology Products Key Oncology Products Bard - Annual Oncology Sales, 2005-2008 Bard – Recent Oncology Product FDA Approvals Surgical Specialty Products Key Surgical Specialty Products Bard - Annual Surgical Specialty Sales, 2005-2008 Bard – Recent Surgical Specialty Product FDA Approvals RESEARCH AND DEVELOPMENT Bard - Breakdown of Annual R&D Expenses, 2004-2008 Research Projects Ventrio Hernia Patch High-Density Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation (MAGELLAN) RESTORE Study Research Agreements Philips TyRx Pharma MANUFACTURING AND DISTRIBUTION Bard – Principal Offices and Manufacturing Locations AGREEMENTS Agreements Summary RTI Biologics Thermal Scalpel Philips Medegen Genzyme Enpath Medical CardioTech International (now AdvanSource Biomaterials) Mentor Tissue Science Laboratories Mediwatch Floreane Medical Implants Specialized Health Products International Endologix Collagen IS Pharma (formerly Maelor) Integra LifeSciences Supply Agreements Premier Purchasing Partners Novation MERGERS AND ACQUISITIONS Mergers and Acquisitions Summary Brennen Medical Specialized Health Products International LifeStent Product Line from Edwards Lifesciences Inrad Venetec International PST’s Self-Expanding Stent Assets Genyx Medical Sorenson Medical’s Closed Suction Catheter System Onux Medical Bridger Biomedical Prostate Services of America, Amertek Medical and Alton Design Biomedical Instruments and Products GmbH’s Biopsy Device Source Tech Medical Imagyn Medical Technologies - Rights to Seed Business NMT Medical’s Vena Cava Filter Business Mill-Rose Laboratories Surgical Sense Biosearch Medical Products’ Intermittent Urinary Catheter Business Dymax ProSeed Endomatrix Impra American Hydro-Surgical Instruments Vas Cath Angiomed Cardial Bainbridge Sciences JOINT VENTURES Medicon MINORITY INVESTMENTS Hydromer Navarre Biomedical DIVESTITURES Endoscopic Technologies Business Cardiopulmonary Business Intra-Aortic Balloon Catheter and Pump Business Coronary Cath Lab Business Neonatal Product Line Surgical Suction Product Line Sani-Spec Product Line Sure-Closure System Inspiron Division MedSystems Division Shield Healthcare Centers Electromedical Systems LITIGATION St Francis Medical Center Composix Kugel Claims Covidien W.L. Gore & Associates Department of Health and Human Services KEY CORPORATE EVENTS INDEX OF TABLES: SUMMARY OPERATING RESULTS Recent Key Events Bard - First and Second Quarter 2009 Financial Results Bard - First and Second Quarter 2009 Sales by Product Area Bard - First and Second Quarter 2009 Sales by Geographic Area Bard - Annual Financial Results, 2004-2008 Bard - Annual Sales by Geographic Area, 2005-2008 Bard - Annual Sales by Product Area, 2005-2008 Bard - Five-Year Financial Summary, 2004-2008 Bard – Product Contributions to Net Sales, 2006-2008 Key Vascular Products Bard – Recent Vascular Product FDA Approvals Key Urology Products Bard – Recent Urology Product FDA Approvals Key Oncology Products Bard – Recent Oncology Product FDA Approvals Key Surgical Specialty Products Bard – Recent Surgical Specialty Product FDA Approvals Bard - Breakdown of Annual R&D Expenses, 2004-2008 Bard – Principal Offices and Manufacturing Locations Agreements Summary Mergers and Acquisitions Summary INDEX OF CHARTS: Bard - Annual Revenues and Operating Income, 2004-2008 Bard - Annual Sales by Geographic Area, 2005-2008 Bard - Annual Sales by Product Area, 2005-2008 Bard - 2008 Sales by Product Group Bard - Annual Vascular Sales, 2005-2008 Bard - Annual Urology Sales, 2005-2008 Bard - Annual Oncology Sales, 2005-2008 Bard - Annual Surgical Specialty Sales, 2005-2008

Companies Mentioned

- Pliva - Enhance Pharmaceuticals - Wyeth - Endeavor Pharmaceuticals - Women’s Capital Corporation - Shire Pharmaceuticals